Implantica Ag Stock Net Asset
| IMP-A-SDB | SEK 35.05 1.40 3.84% |
Implantica AG fundamentals help investors to digest information that contributes to Implantica's financial success or failures. It also enables traders to predict the movement of Implantica Stock. The fundamental analysis module provides a way to measure Implantica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Implantica stock.
Implantica |
Implantica AG Company Net Asset Analysis
Implantica's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Implantica AG has a Net Asset of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Medical Devices (which currently averages 0.0) industry. This indicator is about the same for all Sweden stocks average (which is currently at 0.0).
Implantica Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Implantica's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Implantica could also be used in its relative valuation, which is a method of valuing Implantica by comparing valuation metrics of similar companies.Implantica is currently under evaluation in net asset category among its peers.
Implantica Fundamentals
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0674 | |||
| Operating Margin | (24.51) % | |||
| Current Valuation | 5.38 B | |||
| Shares Owned By Institutions | 28.58 % | |||
| Revenue | 707 K | |||
| Gross Profit | (867 K) | |||
| EBITDA | (17.06 M) | |||
| Net Income | (15.36 M) | |||
| Cash And Equivalents | 147.29 M | |||
| Cash Per Share | 2.12 X | |||
| Total Debt | 142 K | |||
| Current Ratio | 53.28 X | |||
| Book Value Per Share | 0.54 X | |||
| Cash Flow From Operations | (11.47 M) | |||
| Earnings Per Share | (0.06) X | |||
| Number Of Employees | 29 | |||
| Beta | 1.34 |
About Implantica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Implantica AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Implantica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Implantica AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Implantica Stock Analysis
When running Implantica's price analysis, check to measure Implantica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Implantica is operating at the current time. Most of Implantica's value examination focuses on studying past and present price action to predict the probability of Implantica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Implantica's price. Additionally, you may evaluate how the addition of Implantica to your portfolios can decrease your overall portfolio volatility.